Timothy Crew - Lannett Chief Executive Officer, Director
| LCIDelisted Stock | USD 0.03 0.0004 1.51% |
CEO
Mr. Timothy C. Crew is the Chief Executive Officer, Director of the Company. Mr. Crew has more than 25 years of experience in the generic and branded pharmaceutical industries, most recently serving as Chief Executive Officer of Cipla North America, a global pharmaceutical company based in Mumbai, India, from 2013 to 2017. Previously, he worked for eight years at Teva Pharmaceuticals Industries Ltd., where he served as Senior Vice President and Commercial Operating Officer of the North American Generics division, the worlds largest generic operation with multibillion dollars of annual sales. Before that, he was Tevas Vice President, Alliances and Business Development. From 2001 to 2004, Mr. Crew was Executive Vice President, North America, for Dr. Reddys Laboratories Ltd. Mr. Crew began his pharmaceutical career at BristolMyers Squibb, where he held a number of senior management positions in global marketing, managed healthcare, marketing, business development and strategic planning. Prior to his pharmaceutical roles, Mr. Crew served in the United States Army, where he rose to the rank of Captain since 2018.
| Age | 62 |
| Tenure | 6 years |
| Phone | 215 333 9000 |
| Web | https://www.lannett.com |
Lannett Management Efficiency
The company has Return on Asset of (0.078) % which means that on every $100 spent on assets, it lost $0.078. This is way below average. Lannett's management efficiency ratios could be used to measure how well Lannett manages its routine affairs as well as how well it operates its assets and liabilities.The company has 614.95 M in debt with debt to equity (D/E) ratio of 5.03, demonstrating that the company may be unable to create cash to meet all of its financial commitments. Lannett Company has a current ratio of 2.35, demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due. Debt can assist Lannett until it has trouble settling it off, either with new capital or with free cash flow. So, Lannett's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Lannett Company sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Lannett to invest in growth at high rates of return. When we think about Lannett's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Found 11 records | CEO Age | ||
| Keith Kendall | Aquestive Therapeutics | 66 | |
| Daniel Myers | Alimera Sciences | 63 | |
| Mark Mallon | Ironwood Pharmaceuticals | 55 | |
| Scott Tarriff | Eagle Pharmaceuticals | 64 | |
| Richard Nanula | Lucy Scientific Discovery | 63 | |
| Nikhil Lalwani | ANI Pharmaceuticals | 46 | |
| Brendan Kennedy | Tilray Inc | 44 | |
| Peter Hecht | Ironwood Pharmaceuticals | 53 | |
| Irwin Simon | Tilray Inc | 66 | |
| Arthur Przybyl | ANI Pharmaceuticals | 61 | |
| James Hall | Lifecore Biomedical | 61 | |
Management Performance
| Return On Asset | -0.078 |
Lannett Company Leadership Team
Elected by the shareholders, the Lannett's board of directors comprises two types of representatives: Lannett inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Lannett. The board's role is to monitor Lannett's management team and ensure that shareholders' interests are well served. Lannett's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Lannett's outside directors are responsible for providing unbiased perspectives on the board's policies.
| David Drabik, Lead Independent Director | ||
| Melissa Rewolinski, Independent Director | ||
| Paul Taveira, Independent Director | ||
| Patrick LePore, Non-Executive Independent Chairman of the Board | ||
| Timothy Crew, Chief Executive Officer, Director | ||
| Albert Paonessa, Director | ||
| Maureen Cavanaugh, Senior Vice President and Chief Commercial Operations Officer | ||
| Kevin Smith, Sr. VP of Sales and Marketing | ||
| Rohit Desai, Vice President of New Product Strategy | ||
| Alicia Evolga, Vice President - Marketing | ||
| John Kozlowski, Chief Financial Officer, Principal Accounting Officer, Vice President - Finance | ||
| Kristie Stephens, Chief Compliance Officer, Vice President | ||
| Arthur Bedrosian, President CEO, Director | ||
| Kristin Arnold, Vice President - Research and Development | ||
| Jeffrey Farber, Chairman of the Board | ||
| Martin Galvan, CFO, Vice President - Finance, Treasurer | ||
| Grant Brock, Vice President - Operations | ||
| Mahendra Dedhiya, Vice President of Scientific Affairs | ||
| Robert Ehlinger, Vice President - Logistics, Chief Information Officer | ||
| John Chapman, Independent Director | ||
| Michael Bogda, President | ||
| James Maher, Independent Director | ||
| John Abt, Vice President and Chief Quality and Operations Officer | ||
| Samuel Israel, Vice President General Counsel, Chief Legal Officer |
Lannett Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Lannett a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Asset | -0.078 | |||
| Profit Margin | (0.62) % | |||
| Operating Margin | (0.21) % | |||
| Current Valuation | 578.81 M | |||
| Shares Outstanding | 10.77 M | |||
| Shares Owned By Insiders | 14.26 % | |||
| Shares Owned By Institutions | 38.90 % | |||
| Number Of Shares Shorted | 1.24 M | |||
| Price To Earning | 92.21 X | |||
| Price To Book | 1.84 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. Note that the Lannett Company information on this page should be used as a complementary analysis to other Lannett's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Consideration for investing in Lannett Stock
If you are still planning to invest in Lannett Company check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Lannett's history and understand the potential risks before investing.
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |